Illumina Corp (ILMN): Rasio rega marang pendapatan

Logo korporat perusahaan Illumina Inc (ILMN)

Illumina, Inc. (ILMN) generates revenue from the sale of DNA sequencing systems and associated reagents. The price-to-sales ratio reflects the market valuation of sales, with the latest value recorded as 6.90. The company assembles its instruments in-house while outsourcing a portion of the electronics. The rollout of NovaSeq X is currently supporting demand, while the impact of oncology diagnostics and legal costs remains moderate.

Illumina, Inc. - Kapitalisasi marang pendapatan ILMN (periode 04.07.2022 - 14.11.2026)

Rincian analitis perusahaan illumina.com (ILMN)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Illumina (ILMN)
Produk asli Illumina, Inc.

The P/S metric determines the market value of a single unit of revenue, allowing for an assessment of the premium investors are willing to pay for current sales volume. The price-to-sales ratio trend reflects a revaluation of Illumina, Inc. (ILMN) amid intensifying competition in DNA sequencing and forced price reductions for services to maintain market share.

Perusahaan pesaing

Rasio rega marang pendapatan A (Agilent)|Multiplikator P/S DGX (questdiagnostics.com)|EXAS: Rasio kapitalisasi marang pendapatan|RVTY: Kapitalisasi marang pendapatan|Multiplikator rega marang pendapatan bio-rad.com (BIO)|NNNN: Multiplikator P/S|Sotera Health - Rasio kapitalisasi pasar marang pendapatan|QDEL (quidel.com) - Multiplikator P/S|OPK: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CDNA (CareDx)|Multiplikator P/S Maravai LifeSciences (MRVI)|Fulgent Genetics, Inc. - Kapitalisasi marang pendapatan|LAB: Rasio kapitalisasi marang pendapatan|Cytek Corp - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan OSUR (OraSure Technologies)|XGN: Multiplikator P/S|MDxHealth - Rasio kapitalisasi pasar marang pendapatan|LUCD (luciddx.com) - Multiplikator P/S|PRE - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Insight Molecular Diagnostics Inc (IMDX)|TRIB - Rega marang dodolan|Multiplikator P/S PRPH (ProPhase Labs, Inc.)|Koefisien rega marang pendapatan ainos.com (AIMD)|Co-Diagnostics Inc - Multiplikator P/S|HSCS - Multiplikator P/S|BMRA (Biomerica Inc) - Kapitalisasi marang pendapatan|CDIO - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Onconetix Inc|VRAX - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan BJDX (Bluejay Diagnostics)|Multiplikator P/S Aspira Women's Health, Inc. (AWH)|Rasio rega marang pendapatan acceleratediagnostics.com AXDX|Kapitalisasi marang volume dodolan CNTG (centogene.com)|ENZ - Rasio rega marang pendapatan|FRES - Multiplikator P/S|GENE: Multiplikator P/S|Kapitalisasi marang pendapatan 23andMe|PMD (Psychemedics Corp.) - Multiplikator P/S